Circadian pattern of intragastric acidity in patients with non-erosive reflux disease (NERD)

Alimentary Pharmacology and Therapeutics

Volumn 17, Issue 3, 2003, Pages 353-359

  Zentilin, P ^a   Dulbecco, P ^a   Bilardi, C ^a   Gambaro, C ^a   Iiritano, E ^a   Biagini, R ^a   Mela, G S ^a   Tessieri, L ^a   Mele, M R ^a   Mansi, C ^a   Pandolfo, N ^a   Vigneri, S ^b   Savarino, V ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CIRCADIAN RHYTHM; CONTROLLED STUDY; DIGESTIVE SYSTEM DISEASE; ENDOSCOPY; ESOPHAGITIS; FEMALE; GASTROESOPHAGEAL REFLUX; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; NON EROSIVE REFLUX DISEASE; PH MEASUREMENT; PRIORITY JOURNAL; REFLUX ESOPHAGITIS; STOMACH PH; SYMPTOM;

ATROPHY; CIRCADIAN RHYTHM; ESOPHAGITIS; FEMALE; GASTRIC ACID; GASTROESOPHAGEAL REFLUX; HUMANS; HYDROGEN-ION CONCENTRATION; MALE; MIDDLE AGED; STOMACH;

EID: 0037328209     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2003.01422.x     Document Type: Article

References (40)

1. Smout AJPM. Endoscopy-negative acid reflux disease. Aliment Pharmacol Ther 1997; 11(Suppl 2): 81-5.
2. Fass R, Fennerty B, Vakil N. Nonerosive reflux disease - current concepts and dilemmas. Am J Gastroenterol 2001; 96: 303-14.
3. Quigley EMM, DiBaise JK. Non-erosive reflux disease: the real problem in gastro-oesophageal reflux disease. Dig Liver Dis 2001; 33: 523-7.
4. Lind T, Havelund T, Carlsson R, et al. Heartburn without esophagitis: efficacy of omeprazole therapy and features determining therapeutic response. Scand J Gastroenterol 1997; 32: 974-9.
5. Richter JE, Peura D, Benjamin SB, et al. Efficacy of omeprazole for the treatment of symptomatic acid reflux disease without esophagitis. Arch Intern Med 2000; 160: 1810-6.
6. Bate CM, Keeling PWN, Axon ATR, et al. Reflux symptom relief with omeprazole in patients without unequivocal oesophagitis. Aliment Pharmacol Ther 1996; 10: 547-55.
7. Cadiot G, Bruhat A, Rigaud D, et al. Multivariate analysis of pathophysiological factors in reflux oesophagitis. Gut 1997; 40: 167-74.
8. Koek GH, Tack J, Sifrim D, et al. The role of acid and duodenal gastroesophageal reflux in symptomatic GERD. Am J Gastroenterol 2001; 96: 2033-40.
9. Sifrim D, Holloway R, Silny J, et al. Composition of the postprandial refluxate in patients with gastroesophageal reflux disease. Am J Gastroenterol 2001; 96: 647-55.
10. Trudgill NJ, Riley SA. Transient lower esophageal sphincter relaxations are no more frequent in patients with gastroesophageal reflux disease than in asymptomatic volunteers. Am J Gastroenterol 2001; 96: 2569-74.
11. Fletcher J, Wirz A, Young J, et al. Unbuffered highly acidic gastric juice exists at the gastroesophageal junction after a meal. Gastroenterology 2001; 121: 775-83.
12. Fimmel CJ, Etienne A, Cilluffo T, et al. Long-term ambulatory gastric pH monitoring: validation of a new method and effect of H2 antagonists. Gastroenterology 1985; 88: 1842-51.
13. Savarino V, Tracci D, Dulbecco P, et al. Negative effect of ranitidine on the results of urea breath test for the diagnosis of Helicobacter pylori. Am J Gastroenterol 2001; 96: 348-52.
14. Dixon MF, Genta RM, Yardley JH, et al. Classification and grading of gastritis, the updated Sydney system. Am J Surg Pathol 1996; 20: 1161-81.
15. Mela GS, Savarino V, Vigneri S. Optimizing the information obtained from continuous 24-hour gastric pH monitoring. Am J Gastroenterol 1992; 87: 961-6.
16. Savarino V, Mela GS, Zentilin P, et al. Gastric aspiration versus antimony and glass pH electrodes. A simultaneous comparative in vivo study. Scand J Gastroenterol 1989; 24: 434-9.
17. Winer BJ, Brown DR, Michels KM. Statistical Principles in Experimental Design, 3rd edn. New York: McGraw-Hill, 1991: 110-20.
18. Johnson LF, DeMeester TR. Twenty-four-hour pH monitoring of the distal esophagus. A quantitative measure of gastroesophageal reflux. Am J Gastroenterol 1974; 62: 325-32.
19. Kahrilas PJ, Quigley EMM. Clinical esophageal pH recording: a technical review for practice guideline development. Gastroenterology 1996; 110: 1982-96.
20. Savarino V, Mela GS, Zentilin P, et al. Time pattern of gastric acidity in Barrett's esophagus. Dig Dis Sci 1996; 41: 1379-83.
21. Mulholland MW, Reid BJ, Levine DS, et al. Elevated gastric acid secretion in patients with Barrett's metaplastic epithelium. Dig Dis Sci 1989; 34: 1329-35.
22. Collen MJ, Johnson DA, Sheridan MJ. Basal acid output and gastric acid hypersecretion in gastroesophageal reflux disease. Correlation with ranitidine therapy. Dig Dis Sci 1994; 39: 410-7.
23. Hirschowitz BI. A critical analysis, with appropriate controls, of gastric acid and pepsin secretion in clinical esophagitis. Gastroenterology 1991; 101: 1149-58.
24. Savarino V, Mela GS, Scalabrini P, et al. 24-hour study of intragastric acidity in duodenal ulcer patients and normal subjects using continuous intraluminal pH-metry. Dig Dis Sci 1988; 33: 1077-80.
25. Savarino V, Mela GS, Zentilin P, et al. Circadian acidity pattern in gastric ulcers at different sites. Am J Gastroenterol 1995; 90: 254-8.
26. O'Connor HJ. Review article: Helicobacter pyllori and gastrooesophageal reflux disease. Clinical implications and management. Aliment Pharmacol Ther 1999; 13: 117-27.
27. Vigneri S, Termini R, Savarino V, et al. Review article: is Helicobacter pylori status relevant in the management of GERD? Aliment Pharmacol Ther 2000; 14(Suppl. 3): 31-42.
28. Wagner S, Freise J, Beholz S, et al. Campylobacter pylori and gastric acidity. Am J Gastroenterol 1989; 84: 201-4.
29. Rademaker JW, Hunt RH. Helicobacter pylori and gastric acid secretion: the ulcer link? Scand J Gastroenterol 1991; 26(Suppl. 187): 71-7.
30. Montbriand JR, Appleman HD, Corner EK, et al. Treatment of Campylobacter pylori does not alter gastric acid secretion. Am J Gastroenterol 1989; 84: 1513-6.
31. Tucci A, Corinaldesi R, Stanghellini V, et al. Helicobacter pylori infection and gastric function in patients with chronic idiopathic dyspepsia. Gastroenterology 1992; 103: 768-74.
32. Schwizer W, Thumshirm M, Dent J, et al. Helicobacter pylori and symptomatic relapse of gastro-oesophageal reflux disease: a randomised controlled trial. Lancet 2001; 357: 1738-42.
33. Bowrey DJ, Clark GWB, Williams GT. Pattern of gastritis in patients with gastro-oesophageal reflux disease. Gut 1999; 45: 798-803.
34. DeVault KR, Castell DO. Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Am J Gastroenterol 1999; 94: 1434-42.
35. Watson RGP, Tham TCK, Johnston BT, et al. Double blind cross-over placebo controlled study of omeprazole in the treatment of patients with reflux symptoms and physiological levels of acid reflux: the 'sensitive esophagus'. Gut 1997; 40: 587-90.
36. Klauser AF, Schindlbeck NE, Muller-Lissner SA. Symptoms in gastro-oesophageal reflux disease. Lancet 1990; 335: 205-8.
37. Orr WC, Allen ML, Robinson M. The pattern of nocturnal and diurnal esophageal acid exposure in the pathogenesis of erosive mucosal damage. Am J Gastroenterol 1994; 89: 509-12.
38. Sifrim D, Silny J, Holloway RH, et al. Patterns of gas and liquid reflux during transient lower esophageal sphincter relaxation: a study using intraluminal electrical impedance. Gut 1999; 44: 47-54.
39. Fass R, Naliboff B, Higa L, et al. Differential effect of long-term oesophageal acid exposure on mechanosensitivity and chemosensitivity in humans. Gastroenterology 1998; 115: 1363-73.
40. Trimble KC, Pryde A, Heading RC. Lowered oesophageal sensory thresholds in patients with symptomatic but no excess gastro-oesophageal reflux: evidence for a spectrum of visceral sensitivity in GORD. Gut 1995; 37: 7-12.